<DOC>
	<DOCNO>NCT02512055</DOCNO>
	<brief_summary>Ketamine provide safety zone sedate spontaneously ventilate child especially remote condition radiotherapy unit sedation essential practice child keep calm motionless In study , investigator plan analyse ketamine dos need recovery time pediatric oncology patient undergo repeat radiotherapy session .</brief_summary>
	<brief_title>Ketamine Tolerance Children After Repeated Administrations During Radiotherapy Sessions</brief_title>
	<detailed_description>Ketamine provide safety zone sedate spontaneously ventilate child especially remote condition radiotherapy unit sedation essential practice child keep calm motionless.However , disagreement ketamine dos need continuous steady level sedation repeat radiotherapy session child . In study , investigator plan analyse ketamine dos need recovery time pediatric oncology patient undergo repeat radiotherapy sessions.After approval Baskent University , School Medicine , Ethics Research Committee ( KA09/247 ) inform consent patient ' guardian , 33 pediatric patient undergo radiotherapy due oncologic disorder enrol receive ketamine 2 mg/kg atropine 10 Î¼g/kg.Patients ' demographic data age , gender , weight , ASA physical status duration total number radiotherapy session note . Total ketamine consumption maintain target sedation level session , additional dose administration recovery time record . The adverse event apnea , laryngospasm , bronchospasm , desaturation , respiratory depression , bradycardia , sedation level deeper superficial intend , excessive salivation , allergy , nausea vomit need emergency medication also note session . The study drug prepare , label administer anesthetist accord study protocol data record anesthetist blind amount study drug use .</detailed_description>
	<mesh_term>Ketamine</mesh_term>
	<criteria>pediatric patient undergo radiotherapy due oncologic disorder Patients younger 1 year old 14 year , patient cardiac , renal liver function abnormality , already sedative drug treatment allergic drug use patient study drug</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>